Skip to main content
. 2013 Feb 1;36(2):189–196. doi: 10.5665/sleep.2370

Figure 3.

Figure 3

Change from baseline in TSTMOTN. Baseline TSTMOTN was derived from the average of values collected during the 2-wk placebo run-in period for those nights study medication was taken. Analysis of covariance model with mean TSTMOTN as the response; treatment and pooled site as fixed effects and average TSTMOTN at baseline as a covariate. *P < 0.02; +P < 0.05. TSTMOTN, subjective total sleep time following middle-of-the-night awakening; ZST 3.5-mg zolpidem tartrate sublingual tablet.